Trade Novavax NVAX

Sell
 Buy

Novavax live chart

5m 15m 30m 1h 4h 1d 1w

instrument_fundamentals

Weekly Search
Weekly
Daily
date Close change Change (%) instr__open High Low

Novavax news

2021 May 11, 13:20

US pre-market: selling unabated

2021 May 06, 08:27

Stocks rally as Fed speakers get back on script, earnings support + Bank of England set to raise forecasts

2021 Feb 28, 07:36

Week Ahead: RBA speaks, US NFPs released & OPEC clash

2020 May 26, 08:04

Leg up: stocks make new ground, travel stocks soar

Latest news

Show more
Ava Grace 2025 Sep 25, 09:20

White House Budget Office Directs Federal Agencies to Prepare for Mass Layoff Plans Amid Shutdown Fears

Liam James 2025 Sep 25, 09:20

Inflation Fears Grow: Is the US Economy Heading Towards Stagflation?

Sophia Claire 2025 Sep 25, 06:20

DoubleLine Capital Flags Concerns Over US Economic Data Quality, Turns to Alternative Sources

Liam James 2025 Sep 25, 04:20

Trump Shifts Ukraine Strategy: Pressure on Europe to Step Up

Sophia Claire 2025 Sep 25, 02:20

Trump Pledges to Arab Leaders He Won't Allow Israel to Annex West Bank

Ava Grace 2025 Sep 25, 01:20

Kremlin Dismisses Trump's Ukraine Stance Shift, Demands 'Real Information'

Emma Rose 2025 Sep 24, 15:20

US Treasury Chief Criticizes Powell's Rate Cut Stance, Praises New Fed Member

Noah Lee 2025 Sep 24, 11:21

Trump Approval Rating Dips Amid Economic Concerns: Reuters/Ipsos Poll

Info

Spread

0.07

Spread (%)

0.8140 %

Leverage

1:10

Overnight Interest Buy

-0.0597 %

Overnight Interest Sell

-0.0292 %

Currency

USD

Trading Hours

Markets closed

Thursday

13:31 - 19:59

Monday

13:31-19:59

Tuesday

13:31-19:59

Wednesday

13:31-19:59

Friday

13:31-19:59

instr__analysis_statistics

instr__open

---

instr__close

---

instr__52week_range

--- – ---

instr__market_cap

1403323136

instr__shares_outstand

162421645

instr__earnings_date

2019-05-10

instr__dividend_date

2019-05-10

instr__ex_dividend_date

instr__forward_annual_dividend_rate

0

instr__forward_annual_dividend_yield

0

instr__eps

2.22

instrument_learn_more

Novavax Novavax Inc
Novavax, Inc., a biotechnology company, engages in the discovering, developing, and commercializing vaccines to protect against serious infectious diseases in the United States, Europe, and internationally. The company offers vaccine platform that combines a recombinant protein approach, nanoparticle technology, and its patented Matrix-M adjuvant to enhance the immune response. The company is commercializing a COVID-19 vaccine, NVX-CoV2373 under the brand names of Nuvaxovid, Covovax, and Novavax COVID-19 Vaccine, adjuvanted for adult and adolescent populations as a primary series and for both homologous and heterologous booster indications. It also developing R21/Matrix-M adjuvant malaria vaccine. Novavax, Inc. was incorporated in 1987 and is headquartered in Gaithersburg, Maryland.
Markets.com Bonus Trading

related_instruments

Asset
Sell
Buy
Change (%)

trade_now_btn

trade_now_btn

trade_now_btn

trade_now_btn
view_all_instruments

latest_education_articles

Show more
Trustpilot